<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>6314070</identifier>
<setSpec>0210-5187</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Espasandín, J</dc:author>
<dc:author>Lasalvia, E</dc:author>
<dc:author>Vignale, R A</dc:author>
<dc:author>Borras, A</dc:author>
<dc:description xml:lang="en">The epidermic chalone receptor of skin with lesion and without lesion are studied on 20 patients with active psoriasis. The testlest were performed before and two month after oral treatment with RO 10-9359. Roche. The results show significant variation with an increased a the number of receptors after treatment. As these receptors are in the cell membrane, the authors consider that RO 10-9359 action in on the membrane and its surrounding, making in possible to the epithelial cell to begin its autoregulation, autocontrol and differentiation when the specific activity of the chalones become normal.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:date>1983 </dc:date>
<dc:title xml:lang="es">Receptores de chalonas epidérmicas en psoriasis tratados con retinoide: Ro 10-9359</dc:title>
<dc:title xml:lang="en">[Epidermic chalone receptors in psoriasis treated with retinoid:Ro 10-9359].</dc:title>
<dc:publisher>Medicina cutanea ibero-latino-americana</dc:publisher>
</metadata>
</record>
</pubmed-document>
